{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:40:09Z","timestamp":1777426809989,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T00:00:00Z","timestamp":1366156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s40264-013-0044-8","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T11:14:17Z","timestamp":1366110857000},"page":"747-756","source":"Crossref","is-referenced-by-count":22,"title":["Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study"],"prefix":"10.1007","volume":"36","author":[{"given":"Peter Usman","family":"Bassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeline I.","family":"Osakwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambrose","family":"Isah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Comfort","family":"Suku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musa","family":"Kalat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iliya","family":"Jalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robinson Daniel","family":"Wammanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Ugochukwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olubukula","family":"Adesina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eno Etim","family":"Nyong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Osungwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanti","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvester Chigozie","family":"Nwoasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Wallberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,17]]},"reference":[{"key":"44_CR1","unstructured":"Federal Ministry of Health, Abuja. National Strategic Plan for Roll Back Malaria in Nigeria. Federal Ministry of Health, Nigeria. 2001; 8."},{"key":"44_CR2","volume-title":"The National Health Policy of Nigeria","author":"Federal Ministry of Health","year":"1992","unstructured":"Federal Ministry of Health. The National Health Policy of Nigeria. Lagos: Federal Ministry of Health; 1992."},{"key":"44_CR3","unstructured":"Snow RW, Craig MH, Newton CR, Steketee RW. The public health burden of Plasmodium falciparum malaria in Africa. Deriving the numbers. In: Disease control priorities project. Bethesda, Maryland: Fogarty International Center, National Institute of Health; Working paper 2003; No 11."},{"key":"44_CR4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature03342","volume":"434","author":"RW Snow","year":"2005","unstructured":"Snow RW, Guerra CA, Noor AM, et al. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005;434:214\u20137.","journal-title":"Nature"},{"key":"44_CR5","unstructured":"Federal Ministry of Health, Abuja. National guidelines for diagnosis and treatment of malaria (3rd Ed. June 2011), p. 16\u201317. http:\/\/nmcpnigeria.org\/f\/case-management\/2011%20National%20Policy%20on%20Diagnosis%20and%20Treatment%20of%20Malaria.pdf ."},{"key":"44_CR6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-8510(00)00105-6","volume":"54","author":"O Onwujekwe","year":"2000","unstructured":"Onwujekwe O, Chima R, Okonkwo P. Economic burden of malaria illness on households versus that of all other illness episodes. A study in five malaria holoendemic Nigerian communities. Health Policy. 2000;54:143\u201359.","journal-title":"Health Policy"},{"key":"44_CR7","unstructured":"Paediatric Association of Nigeria. 1994;1:5."},{"key":"44_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0001-706X(90)90061-4","volume":"48","author":"GC Ejezie","year":"1991","unstructured":"Ejezie GC, Ezednachi EN, Usanga EA, et al. Malaria and its treatment in rural villages of Aboh Mbaise, Imo State Nigeria. Acta Trop. 1991;48:17\u201324.","journal-title":"Acta Trop"},{"key":"44_CR9","unstructured":"Mokuolu O. Current trends in management of malaria. A paper presented at the inauguration ceremony of the National Malarial Drug Policy Implementation Transition Committee, March 24th 2005."},{"issue":"4","key":"44_CR10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0035-9203(02)90378-0","volume":"96","author":"PE Olumese","year":"2002","unstructured":"Olumese PE, Amodu OK, Bjorkman A, et al. Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children. Trans R Soc Trop Med Hyg. 2002;96(4):418\u201320.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"44_CR11","unstructured":"World Health Organization. Monitoring antimalarial drug resistance. Report of a WHO Consultation 3\u20135 December 2001. Geneva, Switzerland. 2002; WHO\/CDS\/RBM\/2002.2039-2072."},{"key":"44_CR12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.3317830","volume":"238","author":"DJ Krogstad","year":"1987","unstructured":"Krogstad DJ, Gluzman IY, Kyle DE, et al. Efflux of Chloroquine from Plasmodium falciparum: mechanism of Chloroquine resistance. Science. 1987;238:1283\u20135.","journal-title":"Science"},{"key":"44_CR13","unstructured":"Olumese PE: Global antimalarial drug policy database. Antimalarial treatment policies for P. falciparum and P. vivax by country in WHO African and Eastern Mediterranean region [April 2007 update]. World Health Organization, Geneva, Switzerland; 2007."},{"key":"44_CR14","doi-asserted-by":"crossref","unstructured":"Trape JF, Pison G, Preziosi MP, et al. Impact of chloroquine resistance on malaria mortality. Comptes Rendus de l Acad\u00e9mie des Sciences \u2013 S\u00e9rie iii, Sciences de la Vie. 1998; 321:689\u201397.","DOI":"10.1016\/S0764-4469(98)80009-7"},{"key":"44_CR15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4269\/ajtmh.2003.68.386","volume":"68","author":"JR Zucker","year":"2003","unstructured":"Zucker JR, Ruebush TK, Obonyo C, et al. The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya. Am J Trop Med Hyg. 2003;68:386\u201390.","journal-title":"Am J Trop Med Hyg"},{"key":"44_CR16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4269\/ajtmh.1999.60.547","volume":"60","author":"R Price","year":"1999","unstructured":"Price R, van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready R, ter Kuile F, Kham A, Chongsuphajaisiddhi T, White NJ, Nosten F. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg. 1999;60:547\u201355.","journal-title":"Am J Trop Med Hyg"},{"key":"44_CR17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2875-5-50","volume":"5","author":"AO Talisuna","year":"2006","unstructured":"Talisuna AO, Staedke SG, D\u2019Alessandro U. Pharmacovigilance of antimalarial treatment in Africa: is it possible? Malar J. 2006;5:50.","journal-title":"Malar J"},{"key":"44_CR18","unstructured":"WHO: The importance of pharmacovigilance: safety monitoring of medicinal products. Geneva; 2002."},{"issue":"Suppl 1","key":"44_CR19","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1475-2875-8-S1-S6","volume":"8","author":"C Falade","year":"2009","unstructured":"Falade C, Manyando C. Safety profile of Coartem: the evidence base. Malar J. 2009;8(Suppl 1):S6.","journal-title":"Malar J"},{"key":"44_CR20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/bmj.39323.586123.BE","volume":"335","author":"M Pirmohamed","year":"2007","unstructured":"Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P. Pharmacovigilance in developing countries. BMJ. 2007;335:462.","journal-title":"BMJ"},{"key":"44_CR21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11536390-000000000-00000","volume":"33","author":"S Olsson","year":"2010","unstructured":"Olsson S, Pal SN, Stergachis A, Couper M. Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis. Drug Saf. 2010;33:689\u2013703.","journal-title":"Drug Saf"},{"key":"44_CR22","unstructured":"World Health Organization (2006). The safety of medicines in public health programmes: Pharmacovigilance an essential tool; 2006. p. 40\u20131. www.who.int\/hiv\/pub\/pharmacovigilance\/safety\/en\/index.html ."},{"key":"44_CR23","unstructured":"World Health Organization. A practical handbook on the pharmacovigilance of antimalarial medicines. 2007. p. 20\u201335."},{"issue":"6 Suppl","key":"44_CR24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","volume":"77","author":"F Nosten","year":"2007","unstructured":"Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007;77(6 Suppl):181\u201392.","journal-title":"Am J Trop Med Hyg"},{"key":"44_CR25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(96)06217-4","volume":"348","author":"P Olliaro","year":"1996","unstructured":"Olliaro P, Nevill C, LeBras J, Ringwald P, Mussano P, Garner P, Brausseur P. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet. 1996;348:1196\u2013201.","journal-title":"Lancet"},{"key":"44_CR26","first-page":"76","volume":"121","author":"DL Kunac","year":"2008","unstructured":"Kunac DL, Harrison-Woolrych M, Tatley MV. Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use. NZ Med J. 2008;121:76\u201389.","journal-title":"NZ Med J"},{"key":"44_CR27","unstructured":"Shen JX. Antimalarial Drug Development in China. Beijing National Institute of Pharmaceutical Research and Development, on behalf of the UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases. 1989. p. 31\u201395."},{"issue":"suppl 1","key":"44_CR28","first-page":"5","volume":"88","author":"XB Guo","year":"1994","unstructured":"Guo XB, Fu LC, Jian HX, Li GQ, Wang XH. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg. 1994;88(suppl 1):5\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"44_CR29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1475-2875-7-106","volume":"7","author":"M-S Catherine","year":"2008","unstructured":"Catherine M-S, Prasanna J, Vincent MY, et al. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Malaria J. 2008;7:106. doi: 10.1186\/1475-2875-7-106.28 .","journal-title":"Malaria J"},{"issue":"27","key":"44_CR30","doi-asserted-by":"crossref","first-page":"19383","DOI":"10.1074\/jbc.274.27.19383","volume":"274","author":"AV Pandey","year":"1999","unstructured":"Pandey AV, Tekwani BL, Singh RL, et al. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. J Biol Chem. 1999;274(27):19383\u20138. doi: 10.1074\/jbc.274.27.19383.3 .","journal-title":"J Biol Chem"},{"key":"44_CR31","doi-asserted-by":"crossref","unstructured":"Fanello CI, Karema C, van Doren W, van Overmeir C, Ngamije D, D'Alessandro U. A randomised trial to assess the safety and efficacy of artemether\u2013lumefantrine (Coartem\u00ae) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. Trans R Soc Trop Med Hyg. 2007;101(4):344\u201350. doi: 10.1016\/j.trstmh.2006.06.010","DOI":"10.1016\/j.trstmh.2006.06.010"},{"issue":"4","key":"44_CR32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-3156.2004.01224.x","volume":"9","author":"H Barennes","year":"2004","unstructured":"Barennes H, Nagot N, Valea I, et al. A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso. Trop Med Int Health. 2004;9(4):438\u201344.","journal-title":"Trop Med Int Health"},{"key":"44_CR33","doi-asserted-by":"crossref","first-page":"529583","DOI":"10.1155\/2009\/529583","volume":"2009","author":"KP Asante","year":"2009","unstructured":"Asante KP, Owusu R, Dosoo D, Awini E, Adjei G, Etego SA, Chandramohan D, Owusu-Agyei S. Adherence to artesunate-amodiaquine therapy for uncomplicated malaria in rural Ghana: a randomised trial of supervised versus unsupervised drug administration. J Trop Med. 2009;2009:529583.","journal-title":"J Trop Med"},{"issue":"2","key":"44_CR34","first-page":"937","volume":"7","author":"R Adisa","year":"2008","unstructured":"Adisa R, Fakeye TO, Dike D. Evaluation of adverse reactions to Amodiaquine- based combination therapy in s Nigerian University Community. Trop J Pharm R. 2008;7(2):937\u201344.","journal-title":"Trop J Pharm R"},{"key":"44_CR35","unstructured":"WHO Guideline. Guideline for the treatment of malaria. 2nd ed. WHO Press, Appia, Geneva; 2010. p 88."},{"key":"44_CR36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2125.1998.00671.x","volume":"45","author":"OO Simooya","year":"1998","unstructured":"Simooya OO, Sijumbil G, Lennard MS, et al. Halofantrine and chloroquine inhibit CYP2D6 activity in healthy Zambians. Br J Clin Pharmacol. 1998;45:315\u20137.","journal-title":"Br J Clin Pharmacol"},{"issue":"355","key":"44_CR37","first-page":"352","volume":"9201","author":"S Lorenz von","year":"2000","unstructured":"von Lorenz S, Paul M, Margaret P, et al. Efficacy of artesunate plus pyrimethamine\/sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomized, controlled trial. Lancet. 2000;9201(355):352\u20137.","journal-title":"Lancet"},{"issue":"20","key":"44_CR38","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1001\/jama.297.20.2210","volume":"297","author":"MD Grant Dorsey","year":"2007","unstructured":"Grant Dorsey MD, Sarah Staedke MD, Tamara DC, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children. A randomized trial. JAMA. 2007;297(20):2210\u20139.","journal-title":"JAMA"},{"key":"44_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JRS-2005-327","volume":"17","author":"AK Akpalu","year":"2005","unstructured":"Akpalu AK, Nyame PK, Dodoo ANO. Amodiaquine- induced dystonic reactions: Case reports and implications for policy change in Ghana. Int J Risk Saf Med. 2005;17:1\u20134.","journal-title":"Int J Risk Saf Med"},{"issue":"8","key":"44_CR40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/BF03261963","volume":"35","author":"J McEwen","year":"2012","unstructured":"McEwen J. Artesunate- and amodiaquine-associated extrapyramidal reactions. A series of 49 cases in Vigibase. Drug Saf. 2012;35(8):667\u201385.","journal-title":"Drug Saf"},{"issue":"suppl 1","key":"44_CR41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0035-9203(94)90469-3","volume":"88","author":"TG Brewer","year":"1994","unstructured":"Brewer TG, Peggins JO, Grate SJ, et al. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg. 1994;88(suppl 1):33\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"44_CR42","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJM199705013361818","volume":"336","author":"LG Miller","year":"1997","unstructured":"Miller LG, Panosian CB. Ataxia and slurred speech after artesunate treatment for falciparum malaria. New Engl J Med. 1997;336:1328.","journal-title":"New Engl J Med"},{"issue":"5980","key":"44_CR43","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.1184785","volume":"328","author":"SH Kappe","year":"2010","unstructured":"Kappe SH, Vaughan AM, Boddey JA, et al. That was then but this is now: malaria research in the time of an eradication agenda. Science. 2010;328(5980):862\u20136. doi: 10.1126\/science.1184785 .","journal-title":"Science"},{"key":"44_CR44","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/clinids\/23.6.1274","volume":"23","author":"THH Chau","year":"1996","unstructured":"Chau THH, Day NPJ, Chuong LV, et al. Black water fever in Southern Vietnam. A prospective descriptive study of 50 cases. Clin Infect Dis. 1996;23:1274\u201381.","journal-title":"Clin Infect Dis"},{"key":"44_CR45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199607113350202","volume":"335","author":"TT Hein","year":"1996","unstructured":"Hein TT, Day NPJ, Phu NH, et al. Controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. New Eng J Med. 1996;335:76\u201383.","journal-title":"New Eng J Med"},{"key":"44_CR46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)60952-7","volume":"37","author":"JN Cumming","year":"1997","unstructured":"Cumming JN, Ploypradith P, Gary HP. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Adv Pharmacol (San Diego). 1997;37:253\u201397.","journal-title":"Adv Pharmacol (San Diego)"},{"key":"44_CR47","unstructured":"Science Daily. New Data Regarding Safety of Artemisinin Combination Therapy for Pregnant Women with Malaria; 2008."},{"key":"44_CR48","unstructured":"World Health Organization. A practical handbook on the pharmacovigilance of antimalarial medicines. WHO Press, World Health Organization, Appia, Geneva, Switzerland. 2007; 27."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0044-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-013-0044-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0044-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:54:47Z","timestamp":1745988887000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-013-0044-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,17]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1007\/s40264-013-0044-8","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,17]]}}}